The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCES INC | COM | 00032Q104 | 22,459 | 764,701 | SH | SOLE | 764,701 | 0 | 0 | ||
ABCAM PLC | ADS | 000380204 | 23,262 | 1,147,588 | SH | SOLE | 1,147,588 | 0 | 0 | ||
ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | 45,284 | 710,000 | SH | SOLE | 710,000 | 0 | 0 | ||
ACCOLADE INC | COM | 00437E102 | 38,923 | 923,000 | SH | SOLE | 923,000 | 0 | 0 | ||
ACELRX PHARMACEUTICALS INC | COM | 00444T100 | 3,896 | 3,819,402 | SH | SOLE | 3,819,402 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 68,458 | 3,803,232 | SH | SOLE | 3,803,232 | 0 | 0 | ||
ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | 23,467 | 1,579,191 | SH | SOLE | 1,579,191 | 0 | 0 | ||
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 11,321 | 2,189,788 | SH | SOLE | 2,189,788 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 12,540 | 1,577,296 | SH | SOLE | 1,577,296 | 0 | 0 | ||
AGILON HEALTH INC | COM | 00857U107 | 185,436 | 7,075,000 | SH | SOLE | 7,075,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 117,968 | 2,556,179 | SH | SOLE | 2,556,179 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 12,710 | 568,701 | SH | SOLE | 568,701 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 133,086 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 32,365 | 305,706 | SH | SOLE | 305,706 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 58,720 | 311,000 | SH | SOLE | 311,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 22,032 | 4,320,000 | SH | SOLE | 4,320,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 9,669 | 1,012,506 | SH | SOLE | 1,012,506 | 0 | 0 | ||
AMRYT PHARMA PLC | SPONSORED ADS | 03217L106 | 15,601 | 1,295,225 | SH | SOLE | 1,295,225 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 14,532 | 535,832 | SH | SOLE | 535,832 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 872 | 26,458 | SH | SOLE | 26,458 | 0 | 0 | ||
APPLIED THERAPEUTICS INC | COM | 03828A101 | 11,648 | 701,680 | SH | SOLE | 701,680 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 95,130 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 47,459 | 577,500 | SH | SOLE | 577,500 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 63,756 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ATAI LIFE SCIENCES NV | SHS | N0731H103 | 4,698 | 317,628 | SH | SOLE | 317,628 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 26,306 | 750,307 | SH | SOLE | 750,307 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 5,180 | 552,252 | SH | SOLE | 552,252 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 2,865 | 459,830 | SH | SOLE | 459,830 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 13,572 | 613,269 | SH | SOLE | 613,269 | 0 | 0 | ||
BAXTER INTL INC | COM | 071813109 | 36,194 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 3,078 | 309,000 | SH | SOLE | 309,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 19,593 | 253,500 | SH | SOLE | 253,500 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 13,952 | 1,165,582 | SH | SOLE | 1,165,582 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 87,353 | 849,659 | SH | SOLE | 849,659 | 0 | 0 | ||
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 20,863 | 1,649,248 | SH | SOLE | 1,649,248 | 0 | 0 | ||
BRIGHT HEALTH GROUP INC | COM | 10920V107 | 14,402 | 1,765,000 | SH | SOLE | 1,765,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 47,217 | 1,600,589 | SH | SOLE | 1,600,589 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 8,781 | 688,149 | SH | SOLE | 688,149 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 17,766 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
COMPUGEN LTD | ORD | M25722105 | 7,664 | 1,283,790 | SH | SOLE | 1,283,790 | 0 | 0 | ||
CONMED CORP | COM | 207410101 | 21,260 | 162,500 | SH | SOLE | 162,500 | 0 | 0 | ||
COVETRUS INC | COM | 22304C100 | 29,450 | 1,623,500 | SH | SOLE | 1,623,500 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 24,283 | 1,075,912 | SH | SOLE | 1,075,912 | 0 | 0 | ||
CYTOKINETICS INC | NOTE 4.000%11/1 | 23282WAA8 | 28,316 | 8,000,000 | PRN | SOLE | 8,000,000 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 8,933 | 376,439 | SH | SOLE | 376,439 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 4,907 | 334,050 | SH | SOLE | 334,050 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 25,429 | 46,500 | SH | SOLE | 46,500 | 0 | 0 | ||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 27,469 | 1,429,921 | SH | SOLE | 1,429,921 | 0 | 0 | ||
EARGO INC | COM | 270087109 | 6,562 | 975,000 | SH | SOLE | 975,000 | 0 | 0 | ||
EDAP TMS S A | SPONSORED ADR | 268311107 | 4,855 | 760,900 | SH | SOLE | 760,900 | 0 | 0 | ||
EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 65,888 | 582,000 | SH | SOLE | 582,000 | 0 | 0 | ||
ENCOMPASS HEALTH CORP | COM | 29261A100 | 37,520 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 18,401 | 3,593,885 | SH | SOLE | 3,593,885 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 4,064 | 508,044 | SH | SOLE | 508,044 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | UNIT 10/23/2027 | G3141W114 | 2,050 | 206,000 | SH | SOLE | 206,000 | 0 | 0 | ||
EVOLENT HEALTH INC | CL A | 30050B101 | 58,125 | 1,875,000 | SH | SOLE | 1,875,000 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 54,407 | 570,000 | SH | SOLE | 570,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 6,520 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
FRESHPET INC | COM | 358039105 | 75,198 | 527,000 | SH | SOLE | 527,000 | 0 | 0 | ||
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 2,083 | 209,332 | SH | SOLE | 209,332 | 0 | 0 | ||
F-STAR THERAPEUTICS INC | COM | 30315R107 | 7,717 | 1,054,232 | SH | SOLE | 1,054,232 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 12,844 | 455,290 | SH | SOLE | 455,290 | 0 | 0 | ||
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 7,511 | 948,327 | SH | SOLE | 948,327 | 0 | 0 | ||
GALERA THERAPEUTICS INC | COM | 36338D108 | 4,603 | 568,252 | SH | SOLE | 568,252 | 0 | 0 | ||
GAMIDA CELL LTD | SHS | M47364100 | 8,418 | 2,147,400 | SH | SOLE | 2,147,400 | 0 | 0 | ||
GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 16,253 | 15,573,000 | PRN | SOLE | 15,573,000 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 34,037 | 2,076,710 | SH | SOLE | 2,076,710 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | 25,002 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
HCA HEALTHCARE INC | COM | 40412C101 | 109,224 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
HEALTH CATALYST INC | COM | 42225T107 | 42,509 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 1,537 | 154,500 | SH | SOLE | 154,500 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 76,897 | 702,000 | SH | SOLE | 702,000 | 0 | 0 | ||
HUMANA INC | COM | 444859102 | 133,089 | 342,000 | SH | SOLE | 342,000 | 0 | 0 | ||
ICOSAVAX INC | COM | 45114M109 | 21,725 | 734,215 | SH | SOLE | 734,215 | 0 | 0 | ||
IDEXX LABS INC | COM | 45168D104 | 111,942 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
IMARA INC | COM | 45249V107 | 3,383 | 829,102 | SH | SOLE | 829,102 | 0 | 0 | ||
IMMUNEERING CORP | CLASS A COM | 45254E107 | 28,935 | 1,089,816 | SH | SOLE | 1,089,816 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 90,642 | 2,445,155 | SH | SOLE | 2,445,155 | 0 | 0 | ||
INNOVAGE HLDG CORP | COM | 45784A104 | 3,470 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
INOZYME PHARMA INC | COM | 45790W108 | 9,852 | 850,015 | SH | SOLE | 850,015 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 124,369 | 437,566 | SH | SOLE | 437,566 | 0 | 0 | ||
INTERSECT ENT INC | COM | 46071F103 | 33,184 | 1,220,000 | SH | SOLE | 1,220,000 | 0 | 0 | ||
INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 119,298 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 74,084 | 2,605,829 | SH | SOLE | 2,605,829 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 26,235 | 448,000 | SH | SOLE | 448,000 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,010 | 206,200 | SH | SOLE | 206,200 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 47,943 | 391,917 | SH | SOLE | 391,917 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 7,665 | 332,986 | SH | SOLE | 332,986 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 15,405 | 822,500 | SH | SOLE | 822,500 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | 43,052 | 732,927 | SH | SOLE | 732,927 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM | 52187K101 | 14,068 | 3,508,270 | SH | SOLE | 3,508,270 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 15,937 | 315,218 | SH | SOLE | 315,218 | 0 | 0 | ||
LIFESTANCE HEALTH GROUP INC | COM | 53228F101 | 24,469 | 1,687,500 | SH | SOLE | 1,687,500 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 13,440 | 641,816 | SH | SOLE | 641,816 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 20,945 | 262,500 | SH | SOLE | 262,500 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 11,696 | 4,832,978 | SH | SOLE | 4,832,978 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 28,485 | 3,020,702 | SH | SOLE | 3,020,702 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 62,540 | 353,514 | SH | SOLE | 353,514 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 30,390 | 1,525,623 | SH | SOLE | 1,525,623 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 100,849 | 1,051,500 | SH | SOLE | 1,051,500 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | NOTE 2.250% 5/1 | 64125CAD1 | 1,336 | 1,000,000 | PRN | SOLE | 1,000,000 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 73,983 | 635,700 | SH | SOLE | 635,700 | 0 | 0 | ||
NEVRO CORP | NOTE 2.750% 4/0 | 64157FAC7 | 675 | 500,000 | PRN | SOLE | 500,000 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | 13,993 | 503,148 | SH | SOLE | 503,148 | 0 | 0 | ||
NOVAVAX INC | COM NEW | 670002401 | 94,326 | 455,000 | SH | SOLE | 455,000 | 0 | 0 | ||
NOVOCURE LTD | ORD SHS | G6674U108 | 20,330 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 9,541 | 318,450 | SH | SOLE | 318,450 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 343 | 134,028 | SH | SOLE | 134,028 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 2,352 | 236,609 | SH | SOLE | 236,609 | 0 | 0 | ||
OAK STR HEALTH INC | COM | 67181A107 | 18,756 | 441,000 | SH | SOLE | 441,000 | 0 | 0 | ||
OLINK HLDG AB | SPONSORED ADS | 680710100 | 12,246 | 505,000 | SH | SOLE | 505,000 | 0 | 0 | ||
ORION ACQUISITION CORP | UNIT 02/19/2026 | 68626A207 | 9,895 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
PACIRA BIOSCIENCES INC | COM | 695127100 | 56,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
PACIRA BIOSCIENCES INC | NOTE 2.375% 4/0 | 695127AD2 | 1,038 | 1,000,000 | PRN | SOLE | 1,000,000 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 8,092 | 1,665,014 | SH | SOLE | 1,665,014 | 0 | 0 | ||
PENUMBRA INC | COM | 70975L107 | 39,309 | 147,500 | SH | SOLE | 147,500 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 5,734 | 1,843,764 | SH | SOLE | 1,843,764 | 0 | 0 | ||
PHREESIA INC | COM | 71944F106 | 59,849 | 970,000 | SH | SOLE | 970,000 | 0 | 0 | ||
POPULATION HEALTH INVS CO IN | UNIT 99/99/9999 | G71716123 | 2,011 | 201,044 | SH | SOLE | 201,044 | 0 | 0 | ||
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 2,112 | 289,754 | SH | SOLE | 289,754 | 0 | 0 | ||
PRELUDE THERAPEUTICS INC | COM | 74065P101 | 11,324 | 362,359 | SH | SOLE | 362,359 | 0 | 0 | ||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 14,466 | 610,136 | SH | SOLE | 610,136 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 50,604 | 710,430 | SH | SOLE | 710,430 | 0 | 0 | ||
PULMONX CORP | COM | 745848101 | 25,186 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 1,370 | 1,500,000 | PRN | SOLE | 1,500,000 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 14,805 | 469,560 | SH | SOLE | 469,560 | 0 | 0 | ||
RENEO PHARMACEUTICALS INC | COM | 75974E103 | 8,517 | 1,143,185 | SH | SOLE | 1,143,185 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 7,995 | 612,180 | SH | SOLE | 612,180 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 17,400 | 4,793,400 | SH | SOLE | 4,793,400 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 12,054 | 403,270 | SH | SOLE | 403,270 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 32,368 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 42,450 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 6,389 | 313,499 | SH | SOLE | 313,499 | 0 | 0 | ||
SHOCKWAVE MED INC | COM | 82489T104 | 45,294 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 28,803 | 1,313,997 | SH | SOLE | 1,313,997 | 0 | 0 | ||
SPERO THERAPEUTICS INC | COM | 84833T103 | 17,334 | 941,543 | SH | SOLE | 941,543 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 9,722 | 1,617,601 | SH | SOLE | 1,617,601 | 0 | 0 | ||
TELEFLEX INCORPORATED | COM | 879369106 | 48,952 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
TEMPEST THERAPEUTICS INC | COM | 87978U108 | 4,488 | 310,161 | SH | SOLE | 310,161 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | COM | G8807B106 | 5,088 | 687,500 | SH | SOLE | 687,500 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | NOTE 3.250%11/0 | 88339KAA0 | 1,391 | 1,500,000 | PRN | SOLE | 1,500,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 36,298 | 1,496,817 | SH | SOLE | 1,496,817 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 3,276 | 3,250,000 | PRN | SOLE | 3,250,000 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 11,036 | 628,500 | SH | SOLE | 628,500 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | UNIT 10/08/2025 | G9127T116 | 2,046 | 206,000 | SH | SOLE | 206,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 72,252 | 801,109 | SH | SOLE | 801,109 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 93,778 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 45,253 | 962,826 | SH | SOLE | 962,826 | 0 | 0 | ||
VINCERX PHARMA INC | COM NEW | 92731L106 | 12,941 | 800,295 | SH | SOLE | 800,295 | 0 | 0 | ||
WARBY PARKER INC | CL A COM | 93403J106 | 34,483 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
WEST PHARMACEUTICAL SVSC INC | COM | 955306105 | 12,736 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 8,910 | 583,100 | SH | SOLE | 583,100 | 0 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 113,584 | 1,077,750 | SH | SOLE | 1,077,750 | 0 | 0 |